OTHER COMMITTEES UNDER THE BOARD OF COMMISSIONERS

The Risk Committee of PT Bio Farma (Persero) has been established since 2009, in accordance with Decree No. KEP-033/DK/BF/V/2009 dated May 15, 2009 on the Risk Committee.

In 2012, the naming of the Risk Committee changed to the Risk and Nomination Committee based on Board of Commissioners Decree No. KEP-02/DK/BF/V/2012 dated 20-Jan-2012 concerning the Appointment of the Risk and Nomination Committee of PT Bio Farma (Persero).

In 2013, the name of the Risk and Nomination Committee changed to the Risk Committee based on the Decree of the Board of Commissioners No. KEP-11/DK/BF/IV/2012 dated 20-Jan-2012 on the Appointment of the Risk and Nomination Committee of PT Bio Farma: KEP-11/DK/BF/IV/2013 dated April 15, 2013 concerning the Appointment of the Risk Committee of PT Bio Farma (Persero) Board of Commissioners of PT Bio Farma (Persero).

In 2014, the name of the Risk Committee changed to the Risk, Development and GCG Committee based on the Decision of the Board of Commissioners No. KEP-02/DK/BF/I/2014: KEP-02/DK/BF/I/2014 dated January 15, 2014.

BASIS FOR THE ESTABLISHMENT OF THE RISK, DEVELOPMENT AND GCG COMMITTEE

1. Law No. 19 of 2003 concerning SOEs Article 70 paragraph 3, requires the Board of Commissioners to form a committee other than the Audit Committee to assist the Board of Commissioners in carrying out its supervisory duties and responsibilities at PT Bio Farma (Persero).
2. Decree of the Minister of SOEs Number: 117/M-MBU/2002 Dated July 31, 2002 which was updated by Regulation of the Minister of SOEs Number: PER-01/MBU/2011 Dated August 1, 2011 concerning the Implementation of Good Corporate Governance in SOEs as last amended by Regulation of the Minister of SOEs Number: PER-09/MBU/2012 Dated July 6, 2012 concerning Amendments to Regulation of the Minister of SOEs Number: PER-01/MBU/2011 concerning the Implementation of Good Corporate Governance in SOEs article 17 paragraph 1 that the organs of the Board of Commissioners consist of:

• Secretary of the Board of Commissioners, if required
• Audit Committee
• Other Committees, if required
• Regulation of the Minister of State-Owned Enterprises Number: PER-12/MBU/2012 concerning Supporting Organs of the Board of Commissioners.

COMPOSITION OF RISK, DEVELOPMENT AND GCG COMMITTEE

Name

Position

Description

Saud Usman

Chairman

April 26, 2018 - present

Decision of the Board of Commissioners Number: KEP-03/DK/BF/04/2018 dated April 26, 2018 concerning Changes in the Composition of the Risk, Development and GCG Committee of PT Bio Farma (Persero) amended by Decision of the Board of Commissioners of PT Bio Farma (Persero) Number: KEP-05/DK/BF/02/2019 dated February 18, 2019 concerning the Composition of the Risk, Development and GCG Committee of PT Bio Farma (Persero)

Mohamad Subuh

Vice Chairman I

April 26, 2018 - July 15, 2019

Decision of the Board of Commissioners Number: KEP-03/DK/BF/04/2018 dated April 26, 2018 concerning Changes in the Composition of the Risk, Development and GCG Committee of PT Bio Farma (Persero)

Oscar Primadi

Vice Chairman II

April 26, 2018 - July 15, 2019

Decree of the Minister of SOEs as the GMS of the Company (Persero) PT Bio Farma Number: SK-150/MBU/07/2019 dated July 16, 2019 concerning the Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma

Elen Setiadi

Vice-Chairman III

July 16, 2019 - present

Decree of the Minister of SOEs as the GMS of the Company (Persero) PT Bio Farma Number: SK-150/MBU/07/2019 dated July 16, 2019 Regarding the Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma

Judi Januadi Endjun

Member (External)

April 26, 2018 - present

Decision of the Board of Commissioners Number: KEP-03/DK/BF/04/2018 dated April 26, 2018 concerning Changes in the Composition of the Risk, Development and GCG Committee of PT Bio Farma (Persero) amended by Decision of the Board of Commissioners of PT Bio Farma (Persero) Number: KEP-05/DK/BF/02/2019 dated February 18, 2019 concerning the Composition of the Risk, Development and GCG Committee of PT Bio Farma (Persero)

Muhammad Budi Prasetyo

Member (External)

April 26, 2018 - present

Decision of the Board of Commissioners of PT Bio Farma (Persero) Number: KEP-03/DK/BF/02/2019 dated February 2, 2019 on the Appointment of Members of the Risk, Development and GCG Committee of PT Bio Farma (Persero)

DESCRIPTION OF DUTIES AND RESPONSIBILITIES OF THE RISK, DEVELOPMENT AND GCG COMMITTEE

Based on the Charter of the Risk, Development and GCG Committee of PT Bio Farma (Persero), the duties and responsibilities of the Risk, Development and GCG Committee are as follows:

1. To review and provide recommendations on the effectiveness of risk management implementation conducted by the Company's Compliance and Risk Management Division;
2. To review the risk assessment by the Compliance and Risk Management Division of the company's material investment plan;
3. Supervising the activities of the Compliance and Risk Management Division in monitoring the implementation of risk mitigation by related work units;
4. To supervise the implementation of Risk, Development and GCG Committee recommendations by the Compliance and Risk Management Division;
5. Evaluating business development or expansion plans;
6. Monitoring the implementation of GCG principles and policies and assisting the Compliance and Risk Management (CRM) Division in periodic GCG assessments by external parties;
7. To analyze and evaluate the proposed Corporate Budget and Activity Plan (RKAP) and annual review of the Corporate Long Term Plan (RJPP) submitted by the Board of Directors;
8. Reviewing the company's risk and risk management information in reports that will be published;
9. Conduct discussions on important risks in units within the Company as needed;
10. Develop a system of assessment and nomination of candidates for the Board of Directors and Board of Commissioners;
11. Provide evaluation and analysis of the Company's employee selection, recruitment, and succession system;
12. Compile the type and amount of salary and honorarium, allowances and facilities that have been/will be given to the Board of Directors and Board of Commissioners to be proposed by the Board of Commissioners to the GMS;
13. Evaluate and analyze the payroll system, honorarium, allowances and facilities that have been/will be given to the management level and employees.

AUTHORITY OF THE RISK, DEVELOPMENT AND GCG COMMITTEE

To support the implementation of its duties and obligations, the Committee is authorized to:

1. Obtain all documents and full, independent, and unrestricted access to company policies related to business development strategy, GCG implementation, risk management, and the company's nomination and remuneration system;
2. Cooperate with the company's management counterparts, including relevant members of the Board of Directors, and especially with the Compliance and Risk Management Division, HR Division, Corporate Strategy, SPI, and other relevant divisions as Risk/Business Process Owner;
3. Reviewing the function of the Compliance and Risk Management Division, especially in coordinating the implementation and supervision of the implementation of GCG principles and the effectiveness of ERM implementation at PT Bio Farma (Persero);
4. Obtain input from external professionals/independent parties when necessary at the company's expense.''